Paxlovid-associated dysgeusia

Oral Dis. 2023 Oct;29(7):2980-2981. doi: 10.1111/odi.14312. Epub 2022 Jul 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents* / adverse effects
  • Dysgeusia* / chemically induced
  • Humans

Substances

  • nirmatrelvir and ritonavir drug combination
  • Antiviral Agents